SCYX - SCYNEXIS names Christine Coyne as chief commercial officer

SCYNEXIS (SCYX) announces the appointment of Christine Coyne as the company's chief commercial officer, effective May 10, 2021.Coyne joins SCYNEXIS with 30 years of experience in launch and commercialization of products across multiple therapeutic areas.Most recently, Coyne served as Senior Vice President, Commercial at Paratek Pharmaceuticals.Coyne will play a significant role in the anticipated U.S. launch and commercialization of Brexafemme, an oral antifungal product candidate for the treatment of vaginal yeast infection, the company said.Shares down nearly 2% premarket.

For further details see:

SCYNEXIS names Christine Coyne as chief commercial officer